Suren G. Dutia's most recent trade in Citius Oncology Inc. was a trade of 125,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Oncology Inc. | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Oncology Inc. | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 15,000 | 15,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 25,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2020 | 35,000 | 35,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Suren G. Dutia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2020 | 25,000 | 25,000 | - | - | Options to Purchase Common Stock |